It is no secret that Catheter-Associated Urinary Tract Infections (CAUTIs) which are extremely virulent, are very dif cult to treat and eradicate.

In double-blinded randomized control trial, of Uroshield, 55 patients in a skilled nursing facility chain who were being treated with long-term indwelling catheters were evaluated. There was a significant difference between the treated group and the placebo group in the number of CFU, as well as on the number of treated UTIs.